News Center |
Client Alerts
|
|
|
|
|
FTC Reviews Biotech Competition
07/10/2009
The Federal Trade Commission (FTC) held hearings on competition policy and biologics, received public
comments from industry stakeholders—drug manufacturers, health insurers, pharmacy benefit managers,
and consumer groups—and recently published a report.
FTC Follow-On Biologics Client Alert 7_10_09.pdf (48 KB)
|
|